Acorah Software Products - Accounts Production 16.5.460 false true 31 July 2024 28 July 2023 false true No description of principal activity 1 August 2024 31 July 2025 31 July 2025 15034340 Dr Marco Spartera Dr Anna Lena Schaupp iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15034340 2024-07-31 15034340 2025-07-31 15034340 2024-08-01 2025-07-31 15034340 frs-core:CurrentFinancialInstruments 2025-07-31 15034340 frs-bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 15034340 frs-bus:FilletedAccounts 2024-08-01 2025-07-31 15034340 frs-bus:Micro-entities 2024-08-01 2025-07-31 15034340 frs-bus:AuditExempt-NoAccountantsReport 2024-08-01 2025-07-31 15034340 frs-bus:Director1 2024-08-01 2025-07-31 15034340 frs-bus:Director1 2024-07-31 15034340 frs-bus:Director1 2025-07-31 15034340 frs-bus:Director2 2024-08-01 2025-07-31 15034340 2023-07-27 15034340 2024-07-31 15034340 2023-07-28 2024-07-31 15034340 frs-core:CurrentFinancialInstruments 2024-07-31
Registered number: 15034340
Oxford Cardiovascular Health Ltd
Unaudited Financial Statements
For The Year Ended 31 July 2025
TaxAssist Accountants
Balance Sheet
Registered number: 15034340
2025 2024
£ £
Fixed assets 14,856 100
Current assets 100,085 77,856
Prepayments and accrued income 4,120 7,430
Creditors: Amounts Falling Due Within One Year (32,985 ) (19,009 )
NET CURRENT ASSETS 71,220 66,277
TOTAL ASSETS LESS CURRENT LIABILITIES 86,076 66,377
Accruals and deferred income (1,172 ) (1,481 )
NET ASSETS 84,904 64,896
CAPITAL AND RESERVES 84,904 64,896

Notes

1. General Information
Oxford Cardiovascular Health Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15034340 . The registered office is 265 Cowley Road, Oxford, OX4 1XQ.
2. Average Number of Employees
Average number of employees, including directors, during the year was  2 (2024: 2)
2 2
3. Directors Advances, Credits and Guarantees
Included within Debtors are the following loans to directors:
As at 1 August 2024 Amounts advanced Amounts repaid Amounts written off As at 31 July 2025
£ £ £ £ £
Dr Marco Spartera 32,032 - 16,911 - 15,121
The above loan is unsecured, interest is charged at 2.25% and it is repayable on demand.
Page 0
Page 1
For the year ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Marco Spartera
Director
05/11/2025